XML 19 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stock appreciation rights (''SARs'')
6 Months Ended
Jun. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock appreciation rights (“SARs”)
6.
Stock appreciation rights (“SARs”)
 
As at June 30, 2016, ASC had granted 1,346,190 SARs (inclusive of 2,964 forfeited SARs) to certain of its officers and directors under its 2013 Equity Incentive Plan. Under a SAR award, the grantee is entitled to receive the appreciation of a share of ASC’s common stock following the grant of the award. Each SAR provides for a payment of an amount equal to the excess, if any, of the fair market value of a share of ASC’s common stock at the time of exercise of the SAR over the per share exercise price of the SAR, multiplied by the number of shares for which the SAR is then exercised. Payment under the SAR will be made in the form of shares of ASC’s common stock, based on the fair market value of a share of ASC’s common stock at the time of exercise of the SAR.
 
The SAR awards provide that in no event will the appreciation per share for any portion of the SAR award be deemed to exceed four times (i.e., 400%) the per share exercise price of the SAR. In other words, the fair market value of a share of our common stock for purposes of calculating the amount payable under the SAR is not deemed to exceed five times (i.e. 500%) the per share exercise price of the SAR. Any appreciation in excess of four times the per share exercise price of the SAR will be disregarded for purposes of calculating the amount payable under the SAR. Vesting on all awards up to July 31, 2016 is subject to certain market conditions being met. On that date the vesting will revert to being solely dependent on time of service. The grant date fair value was calculated by applying a model based on the Monte Carlo simulation. The model inputs were the grant price, dividend yield based on the initial intended dividend set out by the Company, a risk-free rate of return equal to the zero coupon U.S. Treasury bill commensurate with the contractual terms of the units and expected volatility based on the average of the most recent historical volatilities in the Company’s peer group. A summary of awards, simulation inputs and outputs is as follows:
 
 
 
 
 
 
 
 
 
 
 
Monte Carlo Simulation Inputs
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted
Average
Fair
 
Average
 
Date
 
SARs 
Awarded
 
Exercise 
Price
 
Vesting 
Period
 
Grant
Price
 
Dividend
Yield
 
Risk-free
rate of
 Return
 
Expected
Volatility
 
Value
@grant
date
 
Expected
Exercise
Life
 
01-Aug-13
 
 
1,078,125
 
$
14.00
 
5 yrs
 
$
14.00
 
 
2.87
%
 
2.15
%
 
54.89
%
$
4.28
 
4.9 - 6.0 yrs
 
12-Mar-14
 
 
22,118
 
$
13.66
 
3 yrs
 
$
13.66
 
 
2.93
%
 
2.06
%
 
56.31
%
$
4.17
 
4.6 - 5.0 yrs
 
01-Jun-14
 
 
5,595
 
$
13.91
 
3 yrs
 
$
13.91
 
 
2.88
%
 
2.20
%
 
53.60
%
$
4.20
 
4.5 - 5.0 yrs
 
06-Mar-15
 
 
37,797
 
$
10.25
 
3 yrs
 
$
10.25
 
 
3.90
%
 
1.90
%
 
61.38
%
$
2.98
 
4.2 - 5.0 yrs
 
15-Jan-16
 
 
205,519
 
$
9.20
 
3 yrs
 
$
9.20
 
 
6.63
%
 
1.79
%
 
58.09
%
$
2.20
 
4.0 – 5.0 yrs
 
 
The cost of each tranche is being recognized by the Company on a straight line basis. The recognition of share-based compensation costs related to the tranches that vest before July 31, 2016 will be accelerated if the market condition is met and the requisite service period has been completed. The Company’s policy for issuing shares, if exercised, is to register and issue new common shares to the beneficiary. The movement for the period ended June 30, 2016 is set forth below:
 
 
 
No. of Units
 
Weighted average
exercise price
 
Balance as at January 1, 2016
 
 
1,142,056
 
$
13.87
 
SARs granted during the six months ending June 30, 2016
 
 
205,519
 
$
9.20
 
SARs exercised/converted/expired during the six months ending June 30, 2016
 
 
-
 
 
-
 
SARs forfeited during the six months ending June 30, 2016
 
 
(1,385)
 
 
-
 
Balance as at June 30, 2016 (none of which are exercisable or convertible)
 
 
1,346,190
 
$
13.16
 
 
The total cost related to non-vested awards expected to be recognized through 2018 is set forth below:
 
Period
 
TOTAL
 
2016
 
 
1,302,610
 
2017
 
 
457,042
 
2018
 
 
155,219
 
 
 
 
1,914,871